Link to the Department of Health and Ageing homepage.
Link to the Immunise Australia Program homepage.
National Infoline: 1800 671 811

Print page  Decrease text size  Increase text size

Childhood pneumococcal vaccination program common questions & answers for providers

State and Territory information:
  • ACT: (02) 6205 2300
  • NSW: Contact the local Public Health Units (look under "Health" in the White pages)
  • NT: (09) 8922 8315
  • QLD: (07) 3234 1500
  • SA: (08) 8226 7177
  • Tas: 1800 671 738 - (Tasmania Only) | (03) 6222 7724 - (Outside Tasmania)
  • Vic: 1300 882 008
  • WA: (08) 9321 1312

Question and answer fact sheet about the childhood pneumococcal vaccination program, including eligibility.

Who is eligible for free pneumococcal vaccine?
How much invasive pneumococcal disease is there in Australia?
What vaccine is used in this Program?
More information

Who is eligible for free pneumococcal vaccine?

All infants born from 1 January 2005 at the routinely scheduled immunisation encounters at 2, 4 and 6 months of age or at other times if they miss these milestones.

Children in specific high risk groups up to the age of 5 years.

Booster doses for children in specific high risk groups, as required. See Childhood pneumococcal vaccination program - guidelines for providers for more details.

How much invasive pneumococcal disease is there in Australia?

Invasive pneumococcal disease, normally presenting as meningitis, pneumonia and/or bacteraemia, occurs most frequently in young children less than 2 years of age and in adults over 65 years of age.

In 2004, a total of 472 cases of invasive pneumococcal disease in children under two years were notified. Of this group, there were 13 deaths.

Invasive pneumococcal disease first became notifiable nationally in Australia in 2001.

Top of page


What vaccine is used in this Program?

The 7-valent pneumococcal conjugate vaccine (7vPCV; Prevenar®) is administered to children aged 2, 4 and 6 months of age.

Prevenar® should NOT be administered to people aged 65 years and over as part of the National Pneumococcal Vaccination Program for older Australians.

The 23-valent pneumococcal polysaccharide vaccine (23vPPV; PneumoVax®23) is registered for use ONLY in children two years and older and in adults, because this vaccine does not cause an immune reaction in children under two years of age. For this reason, it should not be given to children as part of the National Childhood Pneumococcal Vaccination Program.

Some children do receive PneumoVax®23 as a booster dose after they have completed a primary course of Prevenar®. See Childhood pneumococcal vaccination program - guidelines for providers for more details.

Top of page


More information

Information about the General Practice Immunisation Incentives (GPII) Scheme is available on the Medicare Australia website, or phone 1800 246 101 (free call - 24 hours).

Information about the Australian Childhood Immunisation Register (ACIR) is available on the Medicare Australia website or phone 1800 653 809 (free call).

For technical information refer to the Australian Immunisation Handbook 9th Edition 2008 (NHMRC).

Top of page

Page last modified: 08 April, 2008